TAC was pleased to have been invited to discuss on Lunchtime Live, our lateral flow test that could be vital in the fight against COVID-19. The test, developed by The Antibody Company and our partners in Coronex, revolutionises lateral flow and will be of immense value in detecting the mutations that are arising, increasing test sensitivity and keeping costs down.
- Rapid and competitive quotation
- Flexible project start and end points
- Experienced team and project management
- Real-time project updates and technical support
- No customs delays, no duty and overseas shipping for UK based companies
- Same day shipping
- Specialist problem solvers
De-risk promising early stage technology by using The Antibody Company's integrated research and production facilities and over 20 years' experience for developing diagnostics and therapeutics. Our Virtual Lab packages can speed up the process and save significant up-front expenditure on specialist equipment and staff.
We offer our Virtual Lab expertise for assistance and partnering in grant and commercial applications.
The Antibody Company offers competitive pricing for single phase or the entire process of generating high-quality monoclonal antibodies and assays.